Search Results

You searched for : Empagliflozin

	CDSCO has approved Boehringer Ingelheim's Jardiance for the treatment of heart failure. ... May 20
	US FDA approves Jardiance (empagliflozin) to treat adults living with heart failure with reduced ejection fraction Latest Pharma News Update... Aug 23
	Lupin Receives Tentative Approval for Empagliflozin and Metformin Hydrochloride ER Tablets Empagliflozin and Metformin Hydrochloride Extended-Release (ER) Tablets, are indicated as an adjunct to diet and exercise, to improve glycemic control in adults with type ... Jan 07
	Empagliflozin reduced the risk of first plus recurrent cardiovascular events in adults with type 2 diabetes and established cardiovascular disease in new analysis from the EMPA-REG OUTCOME trial ... Nov 19
	Alembic Pharma receives USFDA tentative approval for Empagliflozin and Linagliptin tablets Empagliflozin and Linagliptin tablets, have an estimated market size of US$ 244 million for twelve months ending June 2020... Aug 27
	Alembic Pharmaceuticals receives USFDA approval for Vardenafil Hydrochloride tablets Alembic receives USFDA approval for their erectile dysfunction drug ... Aug 05
	USFDA gives tentative nod to Zydus for Empagliflozin tablets The medication is used to improve blood sugar control in adults with Type 2 diabetes mellitus, along with diet and exercise.... Apr 13
	Consistent cardiovascular benefits shown with empagliflozin treatment regardless of the number of controlled cardiovascular risk factors Post-hoc analysis of the EMPA-REG OUTCOMEÂ® trial in adults with type 2 diabetes and established cardiovascular disease examined the cardiovascular benefits of empagliflozin ... Sep 20
8 Matching result(s) found!

-Advertisements-

Trending Now
	Transforming Brain Healthcare: India's Visionary Task Force for Neurological DisordersApril 25, 2024
	The Battle Against Malaria: Rising Trends and Vaccine InnovationsApril 25, 2024
	Talc and Asbestos Controversy: Inside Johnson & Johnson's Courtroom StruggleApril 25, 2024
	The Hidden Struggles of Parenthood: Addressing Isolation, Loneliness, and BurnoutApril 25, 2024
	FDA Confirms Bird Flu Virus Remnants in Pasteurized Milk: Safety and Regulatory InsightsApril 24, 2024
	Sarvodaya Hospital Redefines Total Knee Replacement Surgery with Augmented Reality April 23, 2024
	Fateh Education announces partnership to expand educational opportunities for Indian studentsApril 23, 2024
	10 Strategies to counter disinformation for the healthcare digital ecosystemApril 23, 2024
	Is Selling Over-the-Counter (OTC) Drugs in General Stores A Step Towards Affordable Healthcare in IndiaApril 23, 2024
	Student Health Crisis: Food Poisoning Incident Strikes Pune Coaching CentreApril 23, 2024
	The Impact of Diabetes on Kidney Health: Diabetic Nephropathy ExplainedApril 23, 2024
	Toddler Hospitalized After Consuming Expired Chocolates: Health Concerns RaisedApril 23, 2024
	After months of diagnostic delay, a migrant worker could access TB services only when a community health worker met himApril 22, 2024
	Indian Spices Contaminated with Cancer-Causing Chemical: Hong Kong Food Regulators Issue WarningApril 22, 2024
	FTCCI organised a Workshop on Rooftop Kitchen GardeningApril 20, 2024
	Children in Cities Exposed to Elevated Lead Levels: Study Reveals Urgent Health ConcernApril 20, 2024
	Biocon Ventures into Weight-Loss Drug Market with Semaglutide DevelopmentApril 20, 2024
	Innovative AI Assistance Empowers Moscow Doctors to Detect Cervical Spine Issues through MRI ScansApril 20, 2024
	Air India Express ties up with AISATS for AeroWash Automated Aircraft Exterior Cleanings April 19, 2024
	IndoSup raises strategic funding led by CCI group promoters Naresh Sharma and Satish Sharma; investors include Yatra.com’s Rohan Mittal April 19, 2024

Search Results

CDSCO has approved Boehringer Ingelheim's Jardiance for the treatment of heart failure.

US FDA approves Jardiance (empagliflozin) to treat adults living with heart failure with reduced ejection fraction

Lupin Receives Tentative Approval for Empagliflozin and Metformin Hydrochloride ER Tablets

Empagliflozin reduced the risk of first plus recurrent cardiovascular events in adults with type 2 diabetes and established cardiovascular disease in new analysis from the EMPA-REG OUTCOME trial

Alembic Pharma receives USFDA tentative approval for Empagliflozin and Linagliptin tablets

Alembic Pharmaceuticals receives USFDA approval for Vardenafil Hydrochloride tablets

USFDA gives tentative nod to Zydus for Empagliflozin tablets

Consistent cardiovascular benefits shown with empagliflozin treatment regardless of the number of controlled cardiovascular risk factors

Trending Now